Some solid insights in the report - and good pickup on the fact that oncology has tended to push down success rates.
I also found it interesting that there is little to no reference to dermatology trials - which IMO highlights the extent of unmet needs across the various conditions BOT is exploring.
Some solid insights in the report - and good pickup on the fact...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $308.8M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 14.8¢ | $2.776M | 18.01M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 1104865 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 830042 | 12 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |